Sunday, July 3, 2022

Movers & Shakers, Jan. 7 - BioSpace

With the turn of the calendar, Biopharma and life sciences organizations have bolstered their leadership teams and board with these Movers & Shakers.

Tarsus Pharmaceuticals – Elizabeth Yeu was appointed to the board of directors of Tarsus. Yeu will continue to serve as the company’s chief medical adviser. She will join the Science and Technology Committee. In addition to serving as Tarsus’ CMA, Yeu is a partner and practicing ophthalmologist at Virginia Eye Consultants and Medical Director at Virginia Surgery Center. Yeu currently serves on the Boards of Directors of STAAR Surgical, Ocular Science, and the Virginia Eye Foundation.

NPC – The National Pharmaceutical Council tapped Sharon Phares as chief medical officer. Phares will replace Robert Dubois, who is retiring from NPC at the end of February 2022. Phares will direct NPC’s research strategy and oversee the organization’s research on policy issues. Prior to joining NPC, Phares was the Senior Vice President of Research at Pharmaceutical Strategies Group, an EPIC company. She also serves as an Adjunct Assistant Professor of Medicine at the Washington University School of Medicine in St. Louis. Before PSG, Phares was the vice president of Research and Education at the Pharmaceutical Benefit Management Institute. She also held senior positions in research and analytics at Laboratory Corporation of America, Walgreens Health Services and Express Scripts Incorporated.

SINTX – Bryan J. McEntire, chief scientific officer...

Read Full Story: https://www.biospace.com/article/movers-and-shakers-jan-7